Christopher Smith, DPM
Foot & Ankle Surgery · Melissa, TXNPI 1245802230
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,931 of the $6,433 with a category attached, or 61.1%. Pylant Medical accounts for 60.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $3,084 and has fallen 84.5% since, to $478 in 2025.
Across 57 payments — averaging $112.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$4K
- Stryker$1K
- Integra Lifesciences Corporation$345
- Medical Device Business Services, Inc.$331
- Orthofix Medical, Inc.$141
- Melinta Therapeutics, LLC$116
- plus $524 from 14 others
What the payments were for
- Food & beverage$2,50239%
- Education$3,93161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 9 | $3,863 |
| Stryker | 18 | $1,113 |
| Integra Lifesciences Corporation | 4 | $345 |
| Medical Device Business Services, Inc. | 2 | $331 |
| Orthofix Medical, Inc. | 2 | $141 |
| Melinta Therapeutics, LLC | 1 | $116 |
| Smith+Nephew | 4 | $107 |
| Flower Orthopedics Coporation | 1 | $86 |
| Innovation Technologies Inc | 3 | $85 |
| Bioventus LLC | 2 | $45 |
| Medtronic | 2 | $34 |
| Johnson & Johnson | 1 | $25 |
| Reprise Biomedical, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $21 |
| Solventum Corporation | 1 | $19 |
| Kerecis Limited | 1 | $16 |
| Lifenet Health | 1 | $15 |
| Hydrofera LLC | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CYTAL$517
- PROstep$169
- INFINITY ADAPTIS$168
- VARIAX$156
- Physio-Stim$123
- Kimyrsa$116
- EASYFUSE$107
- AUGMENT INJECTABLE$105
How this compares
$6,433 in reported general payments places this provider in the 60th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $52 |
| Meloxicam | 13 | $9 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Melissa
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.